Telcon RF Pharmaceutical is currently trading at 6,920 KRW as of 2:31 PM on the 19th, down 4.02% from the previous day. This represents a 30.73% decrease compared to September 24. Telcon RF Pharmaceutical is known as a manufacturer of components for wireless communication equipment.

Today, foreign investors have a tentative net sell of 12,639 shares of Telcon RF Pharmaceutical, and institutions have a net sell of 2,000 shares. Over the past five days, individual investors have net bought 513,010 shares, while foreign investors and institutions have net sold 362,805 shares and 128,172 shares, respectively.


On October 15, Telcon RF Pharmaceutical was a market topic for "rising on news of Humanigen therapeutic clinical trials."




[Table] Foreign and Institutional Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing